Investing.com -- Cryptocurrency Injective (INJ) now has its second exchange-traded fund in development after 21Shares filed paperwork with the Securities and Exchange Commission for an Injective ETF ...
Analysts are forecasting that Injective (INJ) could reach $4.90 by 2030. Feeling confident about this Injective price prediction? You can trade Injective on Coinbase—and if you're new to the platform, ...
“DeFi has proven to be a resilient and reliable option for users in the face of the overarching CeFi collapse in 2022,” said Eric Chen, CEO of Injective Labs. Injective, a layer-1 blockchain protocol ...
Injective, a layer-1 blockchain focused on building financial applications, has launched a $150 million fund ecosystem initiative, the platform’s CEO and co-founder, Eric Chen, told TechCrunch. “We’ve ...
Layer-1 blockchain Injective has rolled out what it calls its most significant upgrade yet: a native Ethereum Virtual Machine (EVM) layer. The upgrade aims to make Injective a go-to platform for ...
INJ takes a spot among the largest cryptos with a financial product exposing it to traditional investors. Asset manager 21Shares has launched an Injective exchange-traded product (ETP) on Euronext ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results